{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:21:48Z","timestamp":1793323308949,"version":"4.5.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-023-03569-2","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T20:03:01Z","timestamp":1679688181000},"page":"2527-2538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The WNT\/\u03b2-catenin system in chronic kidney disease-mineral bone disorder syndrome"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3893-5616","authenticated-orcid":false,"given":"Lingbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Kumi","family":"Adu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7231-4947","authenticated-orcid":false,"given":"Jiancheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"issue":"6","key":"3569_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrneph.2017.52","volume":"13","author":"C Zoccali","year":"2017","unstructured":"Zoccali C, Vanholder R, Massy ZA et al (2017) The systemic nature of CKD. Nat Rev Nephrol 13(6):344\u2013358","journal-title":"Nat Rev Nephrol"},{"issue":"10204","key":"3569_CR2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou M, Wang H, Zeng X et al (2019) Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 394(10204):1145\u20131158","journal-title":"Lancet (London, England)"},{"issue":"7","key":"3569_CR3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2215\/CJN.14180920","volume":"16","author":"D Banerjee","year":"2021","unstructured":"Banerjee D, Rosano G, Herzog CA (2021) Management of heart failure patient with CKD. Clin J Am Soc Nephrol CJASN 16(7):1131\u20131139","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"6","key":"3569_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1681\/ASN.2019020117","volume":"30","author":"L Zanoli","year":"2019","unstructured":"Zanoli L, Lentini P, Briet M et al (2019) Arterial stiffness in the heart disease of CKD. J Am Soc Nephrol 30(6):918\u2013928","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"3569_CR5","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N (2021) Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143(11):1157\u20131172","journal-title":"Circulation"},{"issue":"1","key":"3569_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0092-8674(82)90409-3","volume":"31","author":"R Nusse","year":"1982","unstructured":"Nusse R, Varmus HE (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31(1):99\u2013109","journal-title":"Cell"},{"issue":"6","key":"3569_CR7","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H (2017) Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 169(6):985\u2013999","journal-title":"Cell"},{"issue":"7","key":"3569_CR8","first-page":"426","volume":"12","author":"M Edeling","year":"2016","unstructured":"Edeling M, Ragi G, Huang S, Pavenst\u00e4dt H, Susztak K (2016) Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog nature reviews. Nephrology 12(7):426\u2013439","journal-title":"Nephrology"},{"issue":"7","key":"3569_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/ng.400","volume":"41","author":"CM Karner","year":"2009","unstructured":"Karner CM, Chirumamilla R, Aoki S, Igarashi P, Wallingford JB, Carroll TJ (2009) Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis. Nat Genet 41(7):793\u2013799","journal-title":"Nat Genet"},{"issue":"7022","key":"3569_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nature03158","volume":"433","author":"A Kusserow","year":"2005","unstructured":"Kusserow A, Pang K, Sturm C et al (2005) Unexpected complexity of the Wnt gene family in a sea anemone. Nature 433(7022):156\u2013160","journal-title":"Nature"},{"issue":"6938","key":"3569_CR11","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nature01611","volume":"423","author":"K Willert","year":"2003","unstructured":"Willert K, Brown JD, Danenberg E et al (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423(6938):448\u2013452","journal-title":"Nature"},{"issue":"3","key":"3569_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.devcel.2014.03.016","volume":"29","author":"J Yu","year":"2014","unstructured":"Yu J, Chia J, Canning CA, Jones CM, Bard FA, Virshup DM (2014) WLS retrograde transport to the endoplasmic reticulum during Wnt secretion. Dev Cell 29(3):277\u2013291","journal-title":"Dev Cell"},{"issue":"6588","key":"3569_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/382225a0","volume":"382","author":"P Bhanot","year":"1996","unstructured":"Bhanot P, Brink M, Samos CH et al (1996) A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382(6588):225\u2013230","journal-title":"Nature"},{"issue":"12","key":"3569_CR14","doi-asserted-by":"publisher","first-page":"R405","DOI":"10.1016\/S0960-9822(98)70262-3","volume":"8","author":"YK Xu","year":"1998","unstructured":"Xu YK, Nusse R (1998) The Frizzled CRD domain is conserved in diverse proteins including several receptor tyrosine kinases. Current biol CB 8(12):R405-406","journal-title":"Current biol CB"},{"issue":"2","key":"3569_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1124\/pr.57.2.5","volume":"57","author":"SM Foord","year":"2005","unstructured":"Foord SM, Bonner TI, Neubig RR et al (2005) International Union of pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57(2):279\u2013288","journal-title":"Pharmacol Rev"},{"issue":"1","key":"3569_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.molcel.2016.08.026","volume":"64","author":"MV Gammons","year":"2016","unstructured":"Gammons MV, Renko M, Johnson CM, Rutherford TJ, Bienz M (2016) Wnt signalosome assembly by DEP domain swapping of dishevelled. Mol Cell 64(1):92\u2013104","journal-title":"Mol Cell"},{"issue":"6090","key":"3569_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1126\/science.1222879","volume":"337","author":"CY Janda","year":"2012","unstructured":"Janda CY, Waghray D, Levin AM, Thomas C, Garcia KC (2012) Structural basis of Wnt recognition by Frizzled. Science (New York, NY) 337(6090):59\u201364","journal-title":"Science (New York, NY)"},{"issue":"3","key":"3569_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/dgd.12718","volume":"63","author":"G Colozza","year":"2021","unstructured":"Colozza G, Koo BK (2021) Wnt\/\u03b2-catenin signaling: structure, assembly and endocytosis of the signalosome. Dev Growth Differ 63(3):199\u2013218","journal-title":"Dev Growth Differ"},{"key":"3569_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ceb.2017.10.008","volume":"51","author":"M Gammons","year":"2018","unstructured":"Gammons M, Bienz M (2018) Multiprotein complexes governing Wnt signal transduction. Curr Opin Cell Biol 51:42\u201349","journal-title":"Curr Opin Cell Biol"},{"issue":"15","key":"3569_CR20","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00018-010-0329-3","volume":"67","author":"C Niehrs","year":"2010","unstructured":"Niehrs C, Shen J (2010) Regulation of Lrp6 phosphorylation. Cell Mol Life Sci CMLS 67(15):2551\u20132562","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"3","key":"3569_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.molcel.2015.03.015","volume":"58","author":"X Jiang","year":"2015","unstructured":"Jiang X, Charlat O, Zamponi R, Yang Y, Cong F (2015) Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3\/RNF43 E3 ubiquitin ligases. Mol Cell 58(3):522\u2013533","journal-title":"Mol Cell"},{"issue":"5831","key":"3569_CR22","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1126\/science.1137065","volume":"316","author":"J Bilic","year":"2007","unstructured":"Bilic J, Huang YL, Davidson G et al (2007) Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science (New York, NY) 316(5831):1619\u20131622","journal-title":"Science (New York, NY)"},{"issue":"5","key":"3569_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.cellsig.2009.11.021","volume":"22","author":"C Gao","year":"2010","unstructured":"Gao C, Chen YG (2010) Dishevelled: the hub of Wnt signaling. Cell Signal 22(5):717\u2013727","journal-title":"Cell Signal"},{"issue":"2","key":"3569_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1242\/dev.013540","volume":"135","author":"X Zeng","year":"2008","unstructured":"Zeng X, Huang H, Tamai K et al (2008) Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation\/activation via frizzled, dishevelled and axin functions. Development (Cambridge, England) 135(2):367\u2013375","journal-title":"Development (Cambridge, England)"},{"issue":"13","key":"3569_CR25","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/onc.2016.342","volume":"36","author":"CS Daly","year":"2017","unstructured":"Daly CS, Shaw P, Ordonez LD et al (2017) Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium. Oncogene 36(13):1793\u20131803","journal-title":"Oncogene"},{"issue":"5","key":"3569_CR26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.devcel.2018.02.013","volume":"44","author":"K Saito-Diaz","year":"2018","unstructured":"Saito-Diaz K, Benchabane H, Tiwari A et al (2018) APC inhibits ligand-independent Wnt signaling by the clathrin endocytic pathway. Dev Cell 44(5):566-581.e568","journal-title":"Dev Cell"},{"issue":"7069","key":"3569_CR27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nature04185","volume":"438","author":"X Zeng","year":"2005","unstructured":"Zeng X, Tamai K, Doble B et al (2005) A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438(7069):873\u2013877","journal-title":"Nature"},{"issue":"1","key":"3569_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"BT MacDonald","year":"2009","unstructured":"MacDonald BT, Tamai K, He X (2009) Wnt\/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17(1):9\u201326","journal-title":"Dev Cell"},{"key":"3569_CR29","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","volume":"20","author":"CY Logan","year":"2004","unstructured":"Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781\u2013810","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"7","key":"3569_CR30","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cell.2010.11.034","volume":"143","author":"VF Taelman","year":"2010","unstructured":"Taelman VF, Dobrowolski R, Plouhinec JL et al (2010) Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143(7):1136\u20131148","journal-title":"Cell"},{"key":"3569_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/bs.ctdb.2016.11.011","volume":"123","author":"P Patel","year":"2017","unstructured":"Patel P, Woodgett JR (2017) Glycogen synthase kinase 3: a kinase for all pathways? Curr Top Dev Biol 123:277\u2013302","journal-title":"Curr Top Dev Biol"},{"issue":"3","key":"3569_CR32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.molcel.2013.12.010","volume":"53","author":"M Vinyoles","year":"2014","unstructured":"Vinyoles M, Del Valle-P\u00e9rez B, Curto J et al (2014) Multivesicular GSK3 sequestration upon Wnt signaling is controlled by p120-catenin\/cadherin interaction with LRP5\/6. Mol Cell 53(3):444\u2013457","journal-title":"Mol Cell"},{"issue":"1","key":"3569_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nrm3244","volume":"13","author":"R Dobrowolski","year":"2011","unstructured":"Dobrowolski R, De Robertis EM (2011) Endocytic control of growth factor signalling: multivesicular bodies as signalling organelles. Nat Rev Mol Cell Biol 13(1):53\u201360","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"3569_CR34","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.celrep.2012.09.026","volume":"2","author":"R Dobrowolski","year":"2012","unstructured":"Dobrowolski R, Vick P, Ploper D et al (2012) Presenilin deficiency or lysosomal inhibition enhances Wnt signaling through relocalization of GSK3 to the late-endosomal compartment. Cell Rep 2(5):1316\u20131328","journal-title":"Cell Rep"},{"issue":"23","key":"3569_CR35","doi-asserted-by":"publisher","first-page":"E5317","DOI":"10.1073\/pnas.1804091115","volume":"115","author":"LV Albrecht","year":"2018","unstructured":"Albrecht LV, Ploper D, Tejeda-Mu\u00f1oz N, De Robertis EM (2018) Arginine methylation is required for canonical Wnt signaling and endolysosomal trafficking. Proc Natl Acad Sci USA 115(23):E5317-e5325","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"3569_CR36","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1073\/pnas.1820161116","volume":"116","author":"LV Albrecht","year":"2019","unstructured":"Albrecht LV, Bui MH, De Robertis EM (2019) Canonical Wnt is inhibited by targeting one-carbon metabolism through methotrexate or methionine deprivation. Proc Natl Acad Sci USA 116(8):2987\u20132995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"3569_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/13543776.2019.1567711","volume":"29","author":"X Li","year":"2019","unstructured":"Li X, Wang C, Jiang H, Luo C (2019) A patent review of arginine methyltransferase inhibitors (2010\u20132018). Expert Opin Ther Pat 29(2):97\u2013114","journal-title":"Expert Opin Ther Pat"},{"key":"3569_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134682","author":"M Reyes","year":"2020","unstructured":"Reyes M, Flores T, Betancur D, Pe\u00f1a-Oyarz\u00fan D, Torres VA (2020) Wnt\/\u03b2-catenin signaling in oral carcinogenesis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21134682","journal-title":"Int J Mol Sci"},{"key":"3569_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12030185","author":"JR Mu\u00f1oz-Casta\u00f1eda","year":"2020","unstructured":"Mu\u00f1oz-Casta\u00f1eda JR, Rodelo-Haad C, de Pendon-Ruiz Mier MV, Martin-Malo A, Santamaria R, Rodriguez M (2020) Klotho\/FGF23 and Wnt signaling as important players in the comorbidities associated with chronic kidney disease. Toxins. https:\/\/doi.org\/10.3390\/toxins12030185","journal-title":"Toxins"},{"issue":"7","key":"3569_CR40","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1074\/jbc.M108533200","volume":"277","author":"JM Chong","year":"2002","unstructured":"Chong JM, Uren A, Rubin JS, Speicher DW (2002) Disulfide bond assignments of secreted Frizzled-related protein-1 provide insights about Frizzled homology and netrin modules. J Biol Chem 277(7):5134\u20135144","journal-title":"J Biol Chem"},{"issue":"8","key":"3569_CR41","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nsmb.2081","volume":"18","author":"T Malinauskas","year":"2011","unstructured":"Malinauskas T, Aricescu AR, Lu W, Siebold C, Jones EY (2011) Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol 18(8):886\u2013893","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"3569_CR42","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/hep.30646","volume":"70","author":"N Li","year":"2019","unstructured":"Li N, Wei L, Liu X et al (2019) A Frizzled-like cysteine-rich domain in glypican-3 mediates Wnt binding and regulates hepatocellular carcinoma tumor growth in mice. Hepatology (Baltimore, MD) 70(4):1231\u20131245","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"6","key":"3569_CR43","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.devcel.2015.02.014","volume":"32","author":"X Zhang","year":"2015","unstructured":"Zhang X, Cheong SM, Amado NG et al (2015) Notum is required for neural and head induction via Wnt deacylation, oxidation, and inactivation. Dev Cell 32(6):719\u2013730","journal-title":"Dev Cell"},{"issue":"7542","key":"3569_CR44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature14259","volume":"519","author":"S Kakugawa","year":"2015","unstructured":"Kakugawa S, Langton PF, Zebisch M et al (2015) Notum deacylates Wnt proteins to suppress signalling activity. Nature 519(7542):187\u2013192","journal-title":"Nature"},{"issue":"5","key":"3569_CR45","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1074\/jbc.M115.677807","volume":"291","author":"X Zhang","year":"2016","unstructured":"Zhang X, MacDonald BT, Gao H et al (2016) Characterization of tiki, a new family of Wnt-specific metalloproteases. J Biol Chem 291(5):2435\u20132443","journal-title":"J Biol Chem"},{"issue":"5839","key":"3569_CR46","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1126\/science.1143578","volume":"317","author":"H Liu","year":"2007","unstructured":"Liu H, Fergusson MM, Castilho RM et al (2007) Augmented Wnt signaling in a mammalian model of accelerated aging. Science (New York, NY) 317(5839):803\u2013806","journal-title":"Science (New York, NY)"},{"key":"3569_CR47","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009175","author":"J Green","year":"2014","unstructured":"Green J, Nusse R, van Amerongen R (2014) The role of Ryk and Ror receptor tyrosine kinases in Wnt signal transduction. Cold Spring Harbor Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a009175","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"3569_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/bs.ctdb.2016.09.003","volume":"123","author":"S Stricker","year":"2017","unstructured":"Stricker S, Rauschenberger V, Schambony A (2017) ROR-family receptor tyrosine kinases. Curr Top Dev Biol 123:105\u2013142","journal-title":"Curr Top Dev Biol"},{"issue":"1","key":"3569_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4161\/cc.5.1.2305","volume":"5","author":"KA Kim","year":"2006","unstructured":"Kim KA, Zhao J, Andarmani S et al (2006) R-Spondin proteins: a novel link to beta-catenin activation. Cell cycle (Georgetown, Tex) 5(1):23\u201326","journal-title":"Cell cycle (Georgetown, Tex)"},{"issue":"4","key":"3569_CR50","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.devcel.2004.07.019","volume":"7","author":"O Kazanskaya","year":"2004","unstructured":"Kazanskaya O, Glinka A, del Barco BI, Stannek P, Niehrs C, Wu W (2004) R-Spondin2 is a secreted activator of Wnt\/beta-catenin signaling and is required for Xenopus myogenesis. Dev Cell 7(4):525\u2013534","journal-title":"Dev Cell"},{"issue":"28","key":"3569_CR51","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.1073\/pnas.1106083108","volume":"108","author":"KS Carmon","year":"2011","unstructured":"Carmon KS, Gong X, Lin Q, Thomas A, Liu Q (2011) R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt\/beta-catenin signaling. Proc Natl Acad Sci USA 108(28):11452\u201311457","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7360","key":"3569_CR52","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature10337","volume":"476","author":"W de Lau","year":"2011","unstructured":"de Lau W, Barker N, Low TY et al (2011) Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476(7360):293\u2013297","journal-title":"Nature"},{"issue":"10","key":"3569_CR53","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/embor.2011.175","volume":"12","author":"A Glinka","year":"2011","unstructured":"Glinka A, Dolde C, Kirsch N et al (2011) LGR4 and LGR5 are R-spondin receptors mediating Wnt\/\u03b2-catenin and Wnt\/PCP signalling. EMBO Rep 12(10):1055\u20131061","journal-title":"EMBO Rep"},{"issue":"4","key":"3569_CR54","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1101\/gad.235473.113","volume":"28","author":"W de Lau","year":"2014","unstructured":"de Lau W, Peng WC, Gros P, Clevers H (2014) The R-spondin\/Lgr5\/Rnf43 module: regulator of Wnt signal strength. Genes Dev 28(4):305\u2013316","journal-title":"Genes Dev"},{"issue":"1","key":"3569_CR55","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1124\/pr.117.013896","volume":"70","author":"S Foulquier","year":"2018","unstructured":"Foulquier S, Daskalopoulos EP, Lluri G, Hermans KCM, Deb A, Blankesteijn WM (2018) WNT signaling in cardiac and vascular disease. Pharmacol Rev 70(1):68\u2013141","journal-title":"Pharmacol Rev"},{"issue":"7397","key":"3569_CR56","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nature11019","volume":"485","author":"HX Hao","year":"2012","unstructured":"Hao HX, Xie Y, Zhang Y et al (2012) ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485(7397):195\u2013200","journal-title":"Nature"},{"issue":"5","key":"3569_CR57","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051415","volume":"22","author":"N Giebel","year":"2021","unstructured":"Giebel N, de Jaime-Soguero A, Garc\u00eda Del Arco A et al (2021) USP42 protects ZNRF3\/RNF43 from R-spondin-dependent clearance and inhibits Wnt signalling. EMBO Rep 22(5):e51415","journal-title":"EMBO Rep"},{"issue":"7413","key":"3569_CR58","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nature11308","volume":"488","author":"BK Koo","year":"2012","unstructured":"Koo BK, Spit M, Jordens I et al (2012) Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488(7413):665\u2013669","journal-title":"Nature"},{"key":"3569_CR59","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.33126","author":"AM Lebensohn","year":"2018","unstructured":"Lebensohn AM, Rohatgi R (2018) R-spondins can potentiate WNT signaling without LGRs. Elife. https:\/\/doi.org\/10.7554\/eLife.33126","journal-title":"Elife"},{"key":"3569_CR60","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54469","author":"R Dubey","year":"2020","unstructured":"Dubey R, van Kerkhof P, Jordens I et al (2020) R-spondins engage heparan sulfate proteoglycans to potentiate WNT signaling. Elife. https:\/\/doi.org\/10.7554\/eLife.54469","journal-title":"Elife"},{"issue":"25","key":"3569_CR61","doi-asserted-by":"publisher","first-page":"9759","DOI":"10.1074\/jbc.RA118.002743","volume":"293","author":"S Park","year":"2018","unstructured":"Park S, Cui J, Yu W, Wu L, Carmon KS, Liu QJ (2018) Differential activities and mechanisms of the four R-spondins in potentiating Wnt\/\u03b2-catenin signaling. J Biol Chem 293(25):9759\u20139769","journal-title":"J Biol Chem"},{"issue":"7706","key":"3569_CR62","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41586-018-0118-y","volume":"557","author":"E Szenker-Ravi","year":"2018","unstructured":"Szenker-Ravi E, Altunoglu U, Leushacke M et al (2018) RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4\/5\/6. Nature 557(7706):564\u2013569","journal-title":"Nature"},{"key":"3569_CR63","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06554","author":"TH Chang","year":"2015","unstructured":"Chang TH, Hsieh FL, Zebisch M, Harlos K, Elegheert J, Jones EY (2015) Structure and functional properties of Norrin mimic Wnt for signalling with Frizzled4, Lrp5\/6, and proteoglycan. Elife. https:\/\/doi.org\/10.7554\/eLife.06554","journal-title":"Elife"},{"issue":"21","key":"3569_CR64","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1101\/gad.228544.113","volume":"27","author":"J Ke","year":"2013","unstructured":"Ke J, Harikumar KG, Erice C et al (2013) Structure and function of Norrin in assembly and activation of a Frizzled 4-Lrp5\/6 complex. Genes Dev 27(21):2305\u20132319","journal-title":"Genes Dev"},{"issue":"6889","key":"3569_CR65","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nature756","volume":"417","author":"B Mao","year":"2002","unstructured":"Mao B, Wu W, Davidson G et al (2002) Kremen proteins are Dickkopf receptors that regulate Wnt\/beta-catenin signalling. Nature 417(6889):664\u2013667","journal-title":"Nature"},{"issue":"52","key":"3569_CR66","doi-asserted-by":"publisher","first-page":"8520","DOI":"10.1038\/sj.onc.1207892","volume":"23","author":"A Niida","year":"2004","unstructured":"Niida A, Hiroko T, Kasai M et al (2004) DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin\/TCF pathway. Oncogene 23(52):8520\u20138526","journal-title":"Oncogene"},{"issue":"1","key":"3569_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.devcel.2017.09.011","volume":"43","author":"N Kirsch","year":"2017","unstructured":"Kirsch N, Chang LS, Koch S et al (2017) Angiopoietin-like 4 Is a Wnt signaling antagonist that promotes LRP6 turnover. Dev Cell 43(1):71-82.e76","journal-title":"Dev Cell"},{"issue":"39","key":"3569_CR68","doi-asserted-by":"publisher","first-page":"E9135","DOI":"10.1073\/pnas.1812117115","volume":"115","author":"Y Ding","year":"2018","unstructured":"Ding Y, Colozza G, Sosa EA et al (2018) Bighead is a Wnt antagonist secreted by the Xenopus Spemann organizer that promotes Lrp6 endocytosis. Proc Natl Acad Sci USA 115(39):E9135-e9144","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3569_CR69","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/sj.emboj.7601607","volume":"26","author":"W Luo","year":"2007","unstructured":"Luo W, Peterson A, Garcia BA et al (2007) Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex. EMBO J 26(6):1511\u20131521","journal-title":"EMBO J"},{"issue":"6205","key":"3569_CR70","doi-asserted-by":"publisher","first-page":"1248012","DOI":"10.1126\/science.1248012","volume":"346","author":"H Clevers","year":"2014","unstructured":"Clevers H, Loh KM, Nusse R (2014) Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science (New York, NY) 346(6205):1248012\u201312480128","journal-title":"Science (New York, NY)"},{"issue":"19","key":"3569_CR71","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1242\/dev.033910","volume":"136","author":"R van Amerongen","year":"2009","unstructured":"van Amerongen R, Nusse R (2009) Towards an integrated view of Wnt signaling in development. Development (Cambridge, England) 136(19):3205\u20133214","journal-title":"Development (Cambridge, England)"},{"issue":"12","key":"3569_CR72","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrm3470","volume":"13","author":"C Niehrs","year":"2012","unstructured":"Niehrs C (2012) The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol 13(12):767\u2013779","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"39","key":"3569_CR73","doi-asserted-by":"publisher","first-page":"28980","DOI":"10.1074\/jbc.M702840200","volume":"282","author":"L Ma","year":"2007","unstructured":"Ma L, Wang HY (2007) Mitogen-activated protein kinase p38 regulates the Wnt\/cyclic GMP\/Ca2+ non-canonical pathway. J Biol Chem 282(39):28980\u201328990","journal-title":"J Biol Chem"},{"key":"3569_CR74","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1146\/annurev-cellbio-100814-125315","volume":"31","author":"Y Yang","year":"2015","unstructured":"Yang Y, Mlodzik M (2015) Wnt-Frizzled\/planar cell polarity signaling: cellular orientation by facing the wind (Wnt). Annu Rev Cell Dev Biol 31:623\u2013646","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3569_CR75","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-cellbio-120319-023657","volume":"37","author":"LV Albrecht","year":"2021","unstructured":"Albrecht LV, Tejeda-Mu\u00f1oz N, De Robertis EM (2021) Cell biology of canonical Wnt signaling. Annu Rev Cell Dev Biol 37:369\u2013389","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"3","key":"3569_CR76","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a015081","volume":"5","author":"CM Cruciat","year":"2013","unstructured":"Cruciat CM, Niehrs C (2013) Secreted and transmembrane wnt inhibitors and activators. Cold Spring Harb Perspect Biol 5(3):a015081","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"3569_CR77","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0092-8674(02)00685-2","volume":"108","author":"C Liu","year":"2002","unstructured":"Liu C, Li Y, Semenov M et al (2002) Control of beta-catenin phosphorylation\/degradation by a dual-kinase mechanism. Cell 108(6):837\u2013847","journal-title":"Cell"},{"issue":"20","key":"3569_CR78","doi-asserted-by":"publisher","first-page":"17901","DOI":"10.1074\/jbc.M111635200","volume":"277","author":"M van Noort","year":"2002","unstructured":"van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H (2002) Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem 277(20):17901\u201317905","journal-title":"J Biol Chem"},{"issue":"20","key":"3569_CR79","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1242\/dev.01318","volume":"131","author":"F Cong","year":"2004","unstructured":"Cong F, Schweizer L, Varmus H (2004) Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. Development (Cambridge, England) 131(20):5103\u20135115","journal-title":"Development (Cambridge, England)"},{"issue":"6803","key":"3569_CR80","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/35035124","volume":"407","author":"KI Pinson","year":"2000","unstructured":"Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC (2000) An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407(6803):535\u2013538","journal-title":"Nature"},{"issue":"6803","key":"3569_CR81","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/35035117","volume":"407","author":"K Tamai","year":"2000","unstructured":"Tamai K, Semenov M, Kato Y et al (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407(6803):530\u2013535","journal-title":"Nature"},{"issue":"6112","key":"3569_CR82","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1126\/science.1228734","volume":"338","author":"AR Hern\u00e1ndez","year":"2012","unstructured":"Hern\u00e1ndez AR, Klein AM, Kirschner MW (2012) Kinetic responses of \u03b2-catenin specify the sites of Wnt control. Science (New York, NY) 338(6112):1337\u20131340","journal-title":"Science (New York, NY)"},{"issue":"1","key":"3569_CR83","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"F Yu","year":"2021","unstructured":"Yu F, Yu C, Li F et al (2021) Wnt\/\u03b2-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther 6(1):307","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3569_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1183\/09031936.00142409","volume":"37","author":"EM Pfaff","year":"2011","unstructured":"Pfaff EM, Becker S, G\u00fcnther A, K\u00f6nigshoff M (2011) Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis. Eur Respir J 37(1):79\u201387","journal-title":"Eur Respir J"},{"key":"3569_CR85","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3389\/fimmu.2019.02135","volume":"10","author":"O Silva-Garc\u00eda","year":"2019","unstructured":"Silva-Garc\u00eda O, Valdez-Alarc\u00f3n JJ, Baizabal-Aguirre VM (2019) Wnt\/\u03b2-catenin signaling as a molecular target by pathogenic bacteria. Front Immunol 10:2135","journal-title":"Front Immunol"},{"issue":"1","key":"3569_CR86","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ki.2013.271","volume":"85","author":"Y Fang","year":"2014","unstructured":"Fang Y, Ginsberg C, Sugatani T, Monier-Faugere MC, Malluche H, Hruska KA (2014) Early chronic kidney disease-mineral bone disorder stimulates vascular calcification. Kidney Int 85(1):142\u2013150","journal-title":"Kidney Int"},{"issue":"5","key":"3569_CR87","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI28551","volume":"116","author":"V Krishnan","year":"2006","unstructured":"Krishnan V, Bryant HU, Macdougald OA (2006) Regulation of bone mass by Wnt signaling. J Clin Investig 116(5):1202\u20131209","journal-title":"J Clin Investig"},{"issue":"48","key":"3569_CR88","doi-asserted-by":"publisher","first-page":"17406","DOI":"10.1073\/pnas.0505259102","volume":"102","author":"P Cl\u00e9ment-Lacroix","year":"2005","unstructured":"Cl\u00e9ment-Lacroix P, Ai M, Morvan F et al (2005) Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci USA 102(48):17406\u201317411","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"3569_CR89","doi-asserted-by":"publisher","first-page":"E478","DOI":"10.1073\/pnas.1409857112","volume":"112","author":"X Tu","year":"2015","unstructured":"Tu X, Delgado-Calle J, Condon KW et al (2015) Osteocytes mediate the anabolic actions of canonical Wnt\/\u03b2-catenin signaling in bone. Proc Natl Acad Sci USA 112(5):E478-486","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"3569_CR90","doi-asserted-by":"publisher","first-page":"21162","DOI":"10.1074\/jbc.M501900200","volume":"280","author":"SL Holmen","year":"2005","unstructured":"Holmen SL, Zylstra CR, Mukherjee A et al (2005) Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 280(22):21162\u201321168","journal-title":"J Biol Chem"},{"issue":"12","key":"3569_CR91","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1128\/MCB.01428-09","volume":"30","author":"I Kramer","year":"2010","unstructured":"Kramer I, Halleux C, Keller H et al (2010) Osteocyte Wnt\/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol 30(12):3071\u20133085","journal-title":"Mol Cell Biol"},{"issue":"5","key":"3569_CR92","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1210\/er.2012-1026","volume":"34","author":"SL Dallas","year":"2013","unstructured":"Dallas SL, Prideaux M, Bonewald LF (2013) The osteocyte: an endocrine cell \u2026 and more. Endocr Rev 34(5):658\u2013690","journal-title":"Endocr Rev"},{"issue":"4","key":"3569_CR93","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.bone.2007.12.224","volume":"42","author":"LF Bonewald","year":"2008","unstructured":"Bonewald LF, Johnson ML (2008) Osteocytes, mechanosensing and Wnt signaling. Bone 42(4):606\u2013615","journal-title":"Bone"},{"key":"3569_CR94","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bone.2016.10.010","volume":"96","author":"AH van Lierop","year":"2017","unstructured":"van Lierop AH, Appelman-Dijkstra NM, Papapoulos SE (2017) Sclerostin deficiency in humans. Bone 96:51\u201362","journal-title":"Bone"},{"issue":"1","key":"3569_CR95","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tem.2012.10.003","volume":"24","author":"DM Joiner","year":"2013","unstructured":"Joiner DM, Ke J, Zhong Z, Xu HE, Williams BO (2013) LRP5 and LRP6 in development and disease. Trends Endocrinol Metab 24(1):31\u201339","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"3569_CR96","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1359\/jbmr.080216","volume":"23","author":"X Li","year":"2008","unstructured":"Li X, Ominsky MS, Niu QT et al (2008) Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23(6):860\u2013869","journal-title":"J Bone Miner Res"},{"issue":"23","key":"3569_CR97","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","volume":"22","author":"DG Winkler","year":"2003","unstructured":"Winkler DG, Sutherland MK, Geoghegan JC et al (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22(23):6267\u20136276","journal-title":"EMBO J"},{"issue":"10","key":"3569_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025900","volume":"6","author":"AR Wijenayaka","year":"2011","unstructured":"Wijenayaka AR, Kogawa M, Lim HP, Bonewald LF, Findlay DM, Atkins GJ (2011) Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS ONE 6(10):e25900","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"3569_CR99","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0925-4773(99)00194-X","volume":"89","author":"L Grotewold","year":"1999","unstructured":"Grotewold L, Theil T, R\u00fcther U (1999) Expression pattern of Dkk-1 during mouse limb development. Mech Dev 89(1\u20132):151\u2013153","journal-title":"Mech Dev"},{"issue":"6","key":"3569_CR100","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1359\/jbmr.060311","volume":"21","author":"F Morvan","year":"2006","unstructured":"Morvan F, Boulukos K, Cl\u00e9ment-Lacroix P et al (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21(6):934\u2013945","journal-title":"J Bone Miner Res"},{"issue":"1","key":"3569_CR101","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbrc.2009.09.067","volume":"390","author":"H Nakajima","year":"2009","unstructured":"Nakajima H, Ito M, Morikawa Y et al (2009) Wnt modulators, SFRP-1, and SFRP-2 are expressed in osteoblasts and differentially regulate hematopoietic stem cells. Biochem Biophys Res Commun 390(1):65\u201370","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3569_CR102","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/jbmr.307","volume":"26","author":"MS Ominsky","year":"2011","unstructured":"Ominsky MS, Li C, Li X et al (2011) Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones. J Bone Miner Res 26(5):1012\u20131021","journal-title":"J Bone Miner Res"},{"issue":"1","key":"3569_CR103","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.intimp.2014.11.010","volume":"24","author":"G Feng","year":"2015","unstructured":"Feng G, Chang-Qing Z, Yi-Min C, Xiao-Lin L (2015) Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats. Int Immunopharmacol 24(1):7\u201313","journal-title":"Int Immunopharmacol"},{"key":"3569_CR104","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bone.2014.07.039","volume":"71","author":"H Jin","year":"2015","unstructured":"Jin H, Wang B, Li J et al (2015) Anti-DKK1 antibody promotes bone fracture healing through activation of \u03b2-catenin signaling. Bone 71:63\u201375","journal-title":"Bone"},{"key":"3569_CR105","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bone.2016.10.019","volume":"96","author":"MS Ominsky","year":"2017","unstructured":"Ominsky MS, Boyce RW, Li X, Ke HZ (2017) Effects of sclerostin antibodies in animal models of osteoporosis. Bone 96:63\u201375","journal-title":"Bone"},{"issue":"3","key":"3569_CR106","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/jbmr.2372","volume":"30","author":"SM Moe","year":"2015","unstructured":"Moe SM, Chen NX, Newman CL et al (2015) Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res 30(3):499\u2013509","journal-title":"J Bone Miner Res"},{"issue":"8","key":"3569_CR107","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1681\/ASN.2013080818","volume":"25","author":"Y Fang","year":"2014","unstructured":"Fang Y, Ginsberg C, Seifert M et al (2014) CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol 25(8):1760\u20131773","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"3569_CR108","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1007\/s00198-017-4104-2","volume":"28","author":"J Coulson","year":"2017","unstructured":"Coulson J, Bagley L, Barnouin Y et al (2017) Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults. Osteoporos Int 28(9):2683\u20132689","journal-title":"Osteoporos Int"},{"issue":"6","key":"3569_CR109","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.kint.2016.02.002","volume":"89","author":"OA Agapova","year":"2016","unstructured":"Agapova OA, Fang Y, Sugatani T, Seifert ME, Hruska KA (2016) Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease. Kidney Int 89(6):1231\u20131243","journal-title":"Kidney Int"},{"issue":"1","key":"3569_CR110","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","volume":"90","author":"N Carrillo-L\u00f3pez","year":"2016","unstructured":"Carrillo-L\u00f3pez N, Panizo S, Alonso-Montes C et al (2016) Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int 90(1):77\u201389","journal-title":"Kidney Int"},{"issue":"8","key":"3569_CR111","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/jbmr.1630","volume":"27","author":"Y Sabbagh","year":"2012","unstructured":"Sabbagh Y, Graciolli FG, O\u2019Brien S et al (2012) Repression of osteocyte Wnt\/\u03b2-catenin signaling is an early event in the progression of renal osteodystrophy. J Bone Miner Res 27(8):1757\u20131772","journal-title":"J Bone Miner Res"},{"issue":"10","key":"3569_CR112","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1002\/jbmr.1962","volume":"28","author":"C Li","year":"2013","unstructured":"Li C, Xing Q, Yu B et al (2013) Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH. J Bone Miner Res 28(10):2094\u20132108","journal-title":"J Bone Miner Res"},{"issue":"11","key":"3569_CR113","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1210\/en.2005-0239","volume":"146","author":"T Bellido","year":"2005","unstructured":"Bellido T, Ali AA, Gubrij I et al (2005) Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 146(11):4577\u20134583","journal-title":"Endocrinology"},{"issue":"2","key":"3569_CR114","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cmet.2009.12.007","volume":"11","author":"J Guo","year":"2010","unstructured":"Guo J, Liu M, Yang D et al (2010) Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab 11(2):161\u2013171","journal-title":"Cell Metab"},{"issue":"6","key":"3569_CR115","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/jcb.20506","volume":"95","author":"NH Kulkarni","year":"2005","unstructured":"Kulkarni NH, Halladay DL, Miles RR et al (2005) Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem 95(6):1178\u20131190","journal-title":"J Cell Biochem"},{"issue":"12","key":"3569_CR116","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s11255-016-1379-8","volume":"48","author":"W Lv","year":"2016","unstructured":"Lv W, Guan L, Zhang Y, Yu S, Cao B, Ji Y (2016) Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4. Int Urol Nephrol 48(12):2043\u20132050","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"3569_CR117","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2215\/CJN.07670712","volume":"8","author":"S Pelletier","year":"2013","unstructured":"Pelletier S, Dubourg L, Carlier MC, Hadj-Aissa A, Fouque D (2013) The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol CJASN 8(5):819\u2013823","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"Suppl 1","key":"3569_CR118","doi-asserted-by":"publisher","first-page":"i9","DOI":"10.1093\/ndt\/gfh1002","volume":"19","author":"HH Malluche","year":"2004","unstructured":"Malluche HH, Mawad H, Monier-Faugere MC (2004) The importance of bone health in end-stage renal disease: out of the frying pan, into the fire? Nephrol Dial Transplant 19(Suppl 1):i9-13","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"3569_CR119","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/ndt\/gfv043","volume":"30","author":"CY Yang","year":"2015","unstructured":"Yang CY, Chang ZF, Chau YP et al (2015) Circulating Wnt\/\u03b2-catenin signalling inhibitors and uraemic vascular calcifications. Nephrol Dial Transpl 30(8):1356\u20131363","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"3569_CR120","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12882-019-1543-3","volume":"20","author":"TY Ho","year":"2019","unstructured":"Ho TY, Chen NC, Hsu CY et al (2019) Evaluation of the association of Wnt signaling with coronary artery calcification in patients on dialysis with severe secondary hyperparathyroidism. BMC Nephrol 20(1):345","journal-title":"BMC Nephrol"},{"issue":"3","key":"3569_CR121","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/ATVBAHA.116.308394","volume":"37","author":"I Albanese","year":"2017","unstructured":"Albanese I, Yu B, Al-Kindi H et al (2017) Role of noncanonical Wnt signaling pathway in human aortic valve calcification. Arterioscler Thromb Vasc Biol 37(3):543\u2013552","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"3569_CR122","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.yexcr.2016.06.007","volume":"345","author":"T Cai","year":"2016","unstructured":"Cai T, Sun D, Duan Y et al (2016) WNT\/\u03b2-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression. Exp Cell Res 345(2):206\u2013217","journal-title":"Exp Cell Res"},{"issue":"1","key":"3569_CR123","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12872-016-0362-8","volume":"16","author":"C Freise","year":"2016","unstructured":"Freise C, Kretzschmar N, Querfeld U (2016) Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases. BMC Cardiovasc Disord 16(1):185","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"3569_CR124","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1172\/JCI24140","volume":"115","author":"JS Shao","year":"2005","unstructured":"Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA (2005) Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Investig 115(5):1210\u20131220","journal-title":"J Clin Investig"},{"key":"3569_CR125","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.toxlet.2017.11.033","volume":"284","author":"H Zhang","year":"2018","unstructured":"Zhang H, Chen J, Shen Z et al (2018) Indoxyl sulfate accelerates vascular smooth muscle cell calcification via microRNA-29b dependent regulation of Wnt\/\u03b2-catenin signaling. Toxicol Lett 284:29\u201336","journal-title":"Toxicol Lett"},{"issue":"8","key":"3569_CR126","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1210\/jc.2013-1402","volume":"98","author":"AD Anastasilakis","year":"2013","unstructured":"Anastasilakis AD, Polyzos SA, Gkiomisi A, Bisbinas I, Gerou S, Makras P (2013) Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. J Clin Endocrinol Metab 98(8):3206\u20133212","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"3569_CR127","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1002\/jbmr.1681","volume":"27","author":"D Gatti","year":"2012","unstructured":"Gatti D, Viapiana O, Fracassi E et al (2012) Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab. J Bone Miner Res 27(11):2259\u20132263","journal-title":"J Bone Miner Res"},{"issue":"5","key":"3569_CR128","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1210\/jc.2010-2552","volume":"96","author":"D Gatti","year":"2011","unstructured":"Gatti D, Viapiana O, Idolazzi L, Fracassi E, Rossini M, Adami S (2011) The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1. J Clin Endocrinol Metab 96(5):1555\u20131559","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"3569_CR129","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1056\/NEJMc1402396","volume":"370","author":"P Evenepoel","year":"2014","unstructured":"Evenepoel P, D\u2019Haese P, Brandenburg V (2014) Romosozumab in postmenopausal women with osteopenia. N Engl J Med 370(17):1664","journal-title":"N Engl J Med"},{"issue":"16","key":"3569_CR130","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375(16):1532\u20131543","journal-title":"N Engl J Med"},{"issue":"10102","key":"3569_CR131","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","volume":"390","author":"BL Langdahl","year":"2017","unstructured":"Langdahl BL, Libanati C, Crittenden DB et al (2017) Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet (London, England) 390(10102):1585\u20131594","journal-title":"Lancet (London, England)"},{"issue":"15","key":"3569_CR132","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML et al (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377(15):1417\u20131427","journal-title":"N Engl J Med"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03569-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03569-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03569-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T03:30:26Z","timestamp":1694662226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03569-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":132,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["3569"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03569-2","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"assertion":[{"value":"2 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our study did not involve humans.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}